• ACE2, Diminazene Aceturate, and Septic Cardiomyopathy

  2026-10-10

  A February 2024 mouse study links ACE2 activation with protection from sepsis-induced cardiomyopathy through a MasR–Sirt1 mitochondrial biogenesis pathway. Its pharmacological evidence is mechanistically informative but remains preclinical, and Diminazene Aceturate should be interpreted as a research probe rather than a selective or clinically validated ACE2 therapy.

• Paroxetine Mesylate: Mechanism and Evidence

  2026-10-09

  Paroxetine Mesylate is a Selective serotonin reuptake inhibitor salt with established serotonergic pharmacology and reported interactions with several metabolic and signaling proteins. Peer-reviewed evidence supports its primary SERT mechanism, while oncology, kinase, and antiviral findings remain context-dependent and require independent validation.

• How ω-Agatoxin IVA Remodels Membrane Binding

  2026-10-09

  The reference study combines solution NMR, membrane-mimetic analysis, and functional testing of toxin analogs to explain how ω-agatoxin IVA interacts with lipid environments and Cav2.1 channels. Its central contribution is the identification of a membrane-responsive C-terminal tail and a functionally important arginine-rich core, while also showing why membrane context must be considered when interpreting this P/Q-type calcium channel blocker.

• Metformin HCl and the Next Frontier in Ossification

  2026-10-08

  Metformin Hydrochloride is emerging as a mechanistic research probe at the intersection of metabolism, tendon-derived stem-cell biology, and heterotopic ossification. This thought-leadership analysis examines the reported Nr4a1/Wnt/β-catenin findings, the translational evidence gap, and how researchers can position Metformin HCl within a broader metabolic-signaling strategy.

• PTEN mRNA and Trastuzumab Resistance: Evidence Overview

  2026-10-08

  This scientific overview examines how PTEN restoration by in vitro transcribed mRNA is being studied in trastuzumab-resistant HER2-positive breast cancer. It distinguishes findings from a nanoparticle-based preclinical study from supplier-reported characteristics of EZ Cap™ Human PTEN mRNA (ψUTP), while outlining evidence strength, conceptual applications, and key limitations.

• α-KG, LKB1–AMPK, and HPDLSC Senescence

  2026-10-07

  A 2026 Cellular Signalling study identifies an α-ketoglutarate–LKB1–AMPK axis that links mitochondrial recovery with reduced inflammation-associated senescence in human periodontal ligament stem cells. The findings provide mechanistic support for metabolic approaches to periodontal regeneration, while remaining preclinical and model-dependent.

• α-Bungarotoxin as a Causal Receptor Probe

  2026-10-07

  α-Bungarotoxin enables precise interpretation of nicotinic receptor blockade in cholinergic signaling studies. This article examines how α7 receptor antagonism informed a recent placental necroptosis study, while defining the evidence limits and broader value of this neuroscience research tool.

• Caspase-3 Colorimetric Assay Kit Overview

  2026-10-06

  The APExBIO Caspase-3 Colorimetric Assay Kit (SKU K2008) is described as a biochemical assay for DEVD-dependent caspase-3 activity detection. No matched research paper was provided, so performance, specificity, and application claims remain unverified here.

• Human Sensory Neurons Model HSV-1 Latency

  2026-10-06

  Oh et al. developed a scalable human induced pluripotent stem cell-derived sensory neuron system that supports experimentally defined HSV-1 latency and reactivation. The study strengthens the human relevance of latency research by combining neuronal identity and excitability with virological, transcriptional, and chromatin-based evidence, while remaining an in vitro model rather than a clinical substitute.

• CXCR4 Theranostics in Lymphoma: Evidence Review

  2026-10-05

  Dhamecha and colleagues review how CXCR4-targeted imaging and therapeutic agents could connect lymphoma characterization with precision treatment selection. The paper’s main contribution is a theranostic framework that integrates receptor biology, PET or SPECT ligand development, targeted therapy, and translational limitations rather than reporting a new intervention trial.

• EZ Cap™ Human PTEN mRNA (ψUTP): Evidence to Insight

  2026-10-05

  Explore how EZ Cap™ Human PTEN mRNA (ψUTP) can serve as a mechanistic research tool for studying PTEN restoration, PI3K/Akt signaling, and therapy resistance. This evidence-centered guide separates product design rationale from findings demonstrated in nanoparticle-based cancer models.

• A-Eudesmol and Cav2.1 Channels in Brain Ischemia

  2026-10-04

  Asakura and colleagues linked inhibition of ω-agatoxin IVA-sensitive calcium channels with reduced glutamate release and protection from edema and infarction after focal cerebral ischemia in rats. The study is important because it connects presynaptic calcium-channel pharmacology with an in vivo neuroprotection phenotype, while also showing why selectivity and model-specific evidence must be interpreted cautiously.

• BCA Protein Quantification Kit K4102 Overview

  2026-10-03

  A concise, supplier-documented overview of APExBIO’s BCA Protein Quantification Kit K4102, including its stated assay principle, measurement scope, and evidence limitations.

• Mavorixafor in WHIM Syndrome: Phase 3 Evidence

  2026-10-02

  A placebo-controlled phase 3 trial shows that oral CXCR4 antagonism with mavorixafor can extend neutrophil and lymphocyte availability and reduce infections in patients with WHIM syndrome. The findings support a disease-directed strategy for this rare immunodeficiency while leaving important questions about long-term safety, antibody responses, malignancy risk, and treatment durability unresolved.

• BKT140 (BL-8040) CXCR4 Research Workflows

  2026-10-01

  Build practical CXCR4 studies around BKT140 (BL-8040), from migration and apoptosis assays to tumor-microenvironment and stem-cell mobilization models. This workflow-focused guide emphasizes formulation, controls, quantitative readouts, and troubleshooting for reproducible oncology research.

8482 records 1/566 page Next 12345 下5页 Last page